Testosterone patch transfer study in couples
Part of Hormones & metabolism clinical trials.
This study tests whether testosterone from a skin patch can transfer from one person to another during close contact. It helps understand if wearing the patch could affect a partner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You and your partner must be generally healthy.
- Both partners must be between 18 and 80 years old.
- You must have a body mass index (BMI) between 18 and 30.
- You must be a non-smoker.
- Women who can get pregnant must use hormonal birth control and have a negative pregnancy test.
- You must be willing to have blood drawn and, if you are female, have a urinary catheter placed at two visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new testosterone gel at different doses to see how it affects men with low testosterone (below 300 ng/dL). It aims to find the right dose that safely and effectively raises testosterone levels in men aged 18-75.
This study tests a skin patch that may increase natural peptides in your blood. It aims to see if the patch affects these peptides in healthy adults, which could be a step toward future health benefits.
This study looks at how testosterone therapy affects blood pressure over 24 hours in men with low testosterone. It may help you understand how this treatment could affect your heart health.
This trial tests a new contraceptive patch to see if it can prevent ovulation (the release of an egg). If you are a healthy woman looking for a non-hormonal birth control option, this study may be a good fit.
This study tests whether a new skin patch, DM1001, is safe and how well the body tolerates it. It is for healthy adults who want to help find out if this patch could be used for future treatments.
This study tests a new skin patch that releases two hormones (estradiol and levonorgestrel) to see how it affects the skin. It is for healthy postmenopausal women and checks for any irritation or allergic reactions.
Hear when a new Hypogonadotropism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.